Until you've heard this urgent AI warning from the man who called Nvidia before its 44,000% rise… According to Louis, a massive reset is coming in an obscure corner of the AI market.

This $100 trillion disruption could send some of the world's biggest AI stocks to zero… and one off-the-radar stock soaring… starting now.

Click here for details and Louis' new pick — free.

*This ad is sent on behalf of InvestorPlace Media at 1125 N. Charles Street, Baltimore, Maryland 21201. If you're not interested in this opportunity, please click here.

Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.

👉 Click here to get our weekly Sunday watchlist sent to your cell for free!

Quest Diagnostics (DGX)

Catalyst: Raised guidance, steady testing demand, and a business people use whether markets are brave or terrified

Quest just did something the market still respects: it posted a strong quarter and raised its 2026 forecast. The company lifted its full-year profit and revenue outlook after first-quarter results beat Wall Street estimates, supported by resilient demand for routine diagnostic testing. Shares were up about 4% early after the report. 

That matters because Quest is not trying to sell a dream. It is selling a service that keeps getting used. Preventive care, routine screening, employer testing, physician orders, recurring healthcare behavior. This is not glamorous, but it is durable. In a market where people keep getting distracted by whatever is exploding on the newswire, that kind of repeat demand starts to stand out.

The stock is not a lottery ticket. It is a stability-with-upside idea. If management keeps proving that routine testing demand is broad-based and margins stay healthy, this name can keep grinding higher while more dramatic stocks take turns being untradeable.

What to watch: Whether the raised 2026 guide holds through the next quarter, volume growth in routine testing, and margin follow-through. If those three stay intact, the setup remains clean. 

His official salary? $400,000 a year.

Yet his returns point to something far bigger:

Up to $250,000 per month… from just one place.

It’s not property.
It’s not equities.

So what’s really generating this kind of income — and why is it gaining traction now?

Find out how to get started for under $20

D.R. Horton (DHI)

Catalyst: Housing is still messy, but the largest builder just guided above expectations anyway

D.R. Horton is a good reminder that bad headlines and bad businesses are not the same thing. The company narrowed its fiscal 2026 revenue forecast, but the midpoint still came in above analysts’ expectations at roughly $34.0 billion. Second-quarter revenue dipped 2% to $7.56 billion, and earnings per share fell 13% to $2.24, but both still held up better than the market feared. Shares rose nearly 4% in premarket trading after the report. 

That is a useful signal. Mortgage rates are still high. Affordability is still annoying. Builders are still using incentives. Yet the biggest player in the space is still finding a way to keep the machine moving by leaning into smaller, more affordable homes and rate buydowns. That is not the setup for a booming housing market. It is the setup for a resilient operator taking share in a difficult one.

This is not a chase-it-after-one-good-day stock. It is a name to keep on the screen if the market gives you a better entry. Large builders tend to look smarter when weaker competitors start getting squeezed.

What to watch: Incentive intensity, order trends, gross margin pressure, and whether management keeps guiding above consensus without sounding defensive. 

UnitedHealth Group (UNH)

Catalyst: A real turnaround just got its first believable scoreboard

UnitedHealth finally gave investors something concrete to work with. The company beat first-quarter estimates with adjusted profit of $7.23 per share, 66 cents above forecasts, and raised its annual profit outlook to above $18.25 per share. The stock jumped about 10% after the results. 

This is not just a beat-and-raise headline. It is the first real evidence that the turnaround is moving from slide deck to results. Cost control improved. Government payments helped. Management stayed focused on the core U.S. insurance business. The weak spot remains Optum Health, where operating income dropped 15%, but investors were clearly relieved to see margins rebounding from the 2025 trough. 

The reason this name belongs in this issue is simple. Healthcare demand does not stop because markets get nervous. If the company is finally stabilizing operations and rebuilding confidence, the stock has room to recover without needing the world to become less noisy.

What to watch: Optum margin repair, Medicare utilization trends, and whether management keeps raising the floor on 2026 rather than just defending it. 

No one believed Whitney Tilson when he predicted the collapse of Bear Stearns and Lehman Brothers. Or when he went on 60 Minutes exposing a company poisoning its own customers. (The stock fell nearly 80%.)

Now he has a new warning about what's REALLY around the corner for America's most beloved tech companies.

Watch for free here.

ASML (ASML)

Catalyst: Orders are strong, guidance moved higher, and AI chip demand still looks supply-constrained

ASML raised its 2026 forecast last week as stronger AI-related demand boosted new orders. The company said demand is set to outstrip supply for the foreseeable future, with constraints across markets ranging from AI to smartphones and PCs. That is a very useful sentence when the market keeps asking whether the AI buildout is peaking or merely pausing for breath. 

This is still one of the cleanest picks-and-profits ways to play advanced chip demand without trying to guess which software application wins the week. If the industry wants more leading-edge semiconductors, it still has to go through lithography. That moat is not getting smaller just because the macro is messy.

There is geopolitical risk around the broader semiconductor supply chain, including materials such as helium and neon. But the current setup still favors the company with the hardest-to-replace toolset and an improving order book. In a market full of second-order AI stories, this remains one of the first-order ones. 

What to watch: New-order momentum, delivery cadence, and whether management keeps lifting the 2026 tone instead of just repeating it. 

Citigroup (C)

Catalyst: Volatility turned into revenue, and the stock is finally acting like a large bank investors trust again

Citigroup reported its highest revenue in a decade as first-quarter profit jumped 42%, helped by a surge in trading revenue and stronger investment banking fees. Shares hit their highest level since November 2008 after the results. 

That matters because Citi has spent years being the bank people tolerated rather than the bank people chose. If the firm is finally converting market volatility into real operating momentum while improving its credibility with investors, the stock has more room than a “one good quarter” label suggests.

This is not a pure defensive name, but it is a useful one if you want exposure to earnings power without having to fall in love with every growth story in the market. Big banks do not need calm markets to win. Sometimes they prefer the opposite.

What to watch: Trading and investment banking follow-through, expense discipline, and whether management keeps the turnaround language backed by numbers rather than slogans. 

Final Word

This week’s list is built for readers who want fewer moving targets. Quest has raised guidance on steady testing demand. D.R. Horton is navigating a bad housing backdrop better than feared. UnitedHealth finally has a credible turnaround scoreboard. ASML still sits in the middle of the strongest part of the AI hardware chain. Citi is showing what a cleaner banking story looks like when volatility becomes revenue. 

The common thread is not excitement. It is evidence. These names all have a real number, a real catalyst, and a real reason to stay on the screen even if the macro noise keeps shouting. That is a better place to start than guessing which headline gets walked back next.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.